Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
95.36
-3.76 (-3.79%)
At close: Apr 6, 2026, 4:00 PM EDT
95.54
+0.18 (0.19%)
After-hours: Apr 6, 2026, 7:33 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $18.9 billion as of April 6, 2026. Its market cap has increased by 164.09% in one year.
Market Cap
18.90B
Enterprise Value
17.30B
1-Year Change
164.09%
Ranking
Category
Stock Price
$95.36
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $18.90B, an increase of 1,049.17%. That is a compound annual growth rate of 48.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 18.90B | 22.73% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 28.02B |
| BioNTech SE | 21.88B |
| Roivant Sciences | 20.28B |
| Moderna | 19.51B |
| Incyte | 19.09B |
| Genmab | 16.77B |
| Summit Therapeutics | 15.03B |
| BridgeBio Pharma | 14.18B |